Monoamine oxidase inhibitors in hypertension
- 1 December 1960
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 6 (6), 1146-1151
- https://doi.org/10.1016/0002-9149(60)90379-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- FATAL JAUNDICE AFTER ADMINISTRATION OF BETA-PHENYLISOPROPYLHYDRAZINEJAMA, 1959
- A METHOD FOR MEASUREMENT OF MONOAMINE OXIDASE INHIBITION IN MAN: APPLICATION TO STUDIES ON HYPERTENSIONAnnals of the New York Academy of Sciences, 1959
- IPRONIAZID IN CARDIOVASCULAR THERAPY, WITH SPECIAL REFERENCE TO ITS ACTION IN ANGINA PECTORIS AND BLOOD PRESSUREAnnals of the New York Academy of Sciences, 1959
- EVALUATION OF 2 MONOAMINE OXIDASE INHIBITORS (IPRONIAZID AND JB 516) IN THE THERAPY OF ARTERIAL HYPERTENSIONThe American Journal of the Medical Sciences, 1959
- The application of a monoamine-oxidase inhibitor, 1-phenyl-2-hydrazinopropane (JB-516), to the treatment of primary hypertensionAmerican Heart Journal, 1959
- BETA-PHENYLISOPROPYLHDRAZINE, A POTENT AND LONG ACTING MONOAMINE OXIDASE INHIBITOR1958
- The Effects of Iproniazid Phosphate (Marsilid) on HypertensionAngiology, 1957
- Adrenergic blockade by iproniazidCellular and Molecular Life Sciences, 1955
- CONVULSANT EFFECTS OF ISONIAZIDJAMA, 1953